• Shares of Bruker Corporation (NASDAQ:BRKR) traded higher on Wednesday after Frank Laukien, the chief executive officer of the life sciences firm, purchased over $5M worth of company stock.
• More than 1.6 million shares of Bruker (NASDAQ:BRKR) have changed hands compared to the 65-day average of ~1.2 million as the stock added ~5%, which, if the gain holds, would mark BRKR's best intraday advance in over five years.
• According to an SEC filing on Tuesday, Laukien, who has served as Bruker’s (BRKR) CEO for over thirty years, bought 100K company shares in three transactions.
• His purchases, made at prices ranging from $49.82 to $51.36 on average, were worth more than $5.0M in total.
• Following the transactions conducted on Monday, Laukien, the biggest shareholder of Bruker (BRKR), has increased his direct ownership of company shares to ~38.4 million.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.